 |
|
|
|
region: |
IKZ |
|
| tumor:
All tumors |
|
trial number(s) |
|
phase:
na |
|
status
nation wide:
(re)open |
|
All sites |
|
|
|
| - All sites |
|
CKTO 2004-06 |
|
III |
|
open (01-04-2005) |
|
|
|
Blood, Bone Marrow & Lymph Nodes |
|
|
|
| - Hodgkin Lymphoma |
|
H10, EORTC 20051 |
|
III |
|
open (01-11-2006) |
|
|
|
| - Non-Hodgkin Lymphoma |
|
CKTO 2004-03,HOVON 55 |
|
III |
|
open (10-01-2005) |
|
|
|
| - Non-Hodgkin Lymphoma |
|
CKTO 2006-14,HOVON 84 |
|
III |
|
open (25-10-2007) |
|
|
|
| - Non-Hodgkin Lymphoma |
|
CKTO 2007-10,HOVON 85 |
|
II |
|
open (15-08-2008) |
|
|
|
| - Plasma Cell Tumors |
|
CKTO 2007-09,HOVON 86 |
|
I/II |
|
open (17-12-2009) |
|
|
|
| - Plasma Cell Tumors |
|
HOVON 87,KWF 2008-4246 |
|
III |
|
open (02-03-2009) |
|
|
|
| - ALL |
|
HOVON 100 ALL / EORTC, HOVON 100,KWF 2008-4330 |
|
II/III |
|
open (31-08-2009) |
|
|
|
| - CLL |
|
CKTO 2005-07,HOVON 68 |
|
III |
|
open (05-12-2005) |
|
|
|
| - CLL |
|
CKTO 2007-12,HOVON 88 |
|
II |
|
open (17-11-2008) |
|
|
|
| - AML |
|
AML 19, EORTC 06031 |
|
II/III |
|
re-open (05-09-2007) |
|
|
|
| - AML |
|
HOVON 97,KWF 2008-4291 |
|
III |
|
open (01-07-2009) |
|
|
|
| - AML |
|
HOVON 102,KWF 2009-4464 |
|
III |
|
open (19-03-2010) |
|
|
|
| - MDS |
|
HOVON 89,KWF 2008-4333 |
|
II |
|
open (09-06-2009) |
|
|
|
Breast |
|
|
|
| - Breast |
|
TEAM II, BOOG 2006-04 |
|
III |
|
open (08-03-2007) |
|
|
|
| - Breast |
|
MINDACT, BIG 3-04,BOOG 2005-03,EORTC 10041 |
|
III |
|
open (08-02-2006) |
|
|
|
| - Breast |
|
IDEAL, BOOG 2006-05 |
|
III |
|
open (01-03-2007) |
|
|
|
| - Breast |
|
CANDY, Nederlands Kankerinstituut - Antoni van Leeuwenhoek Ziekenhuis M06HER |
|
III |
|
open (15-11-2007) |
|
|
|
| - Breast |
|
NEO-ZOTAC, BOOG 2010-01,KWF C2010-4682 |
|
III |
|
open (01-07-2010) |
|
|
|
| - Breast, NO high risk or N+ |
|
YOUNG BOOST, BOOG 2004-01,CKTO 2003-13 |
|
III |
|
open (01-08-2004) |
|
|
|
|
|
|
[1-20] van 38 |
 |
|
|
|
|
|
